Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-17-002380
Filing Date
2017-05-01
Accepted
2017-05-01 17:15:07
Documents
2
Period of Report
2017-06-07
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT admp-def14a_060717.htm DEF 14A 876538
2 GRAPHIC proxyamendmentdraft001_v1.jpg GRAPHIC 11219
  Complete submission text file 0001387131-17-002380.txt   893320
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36242 | Film No.: 17801860
SIC: 2834 Pharmaceutical Preparations